Maravai LifeSciences Holdings (MEX:MRVI) Scaled Net Operating Assets: 0.62 (As of Mar. 2026)


MEX:MRVI Maravai LifeSciences Holdings Inc MEX:MRVI
62 GF Score
Price MXN85.00
GF Value MXN52.80
! 8 Warning Signs
View Full Analysis

What is Maravai LifeSciences Holdings Scaled Net Operating Assets?

Maravai LifeSciences Holdings MEX:MRVI 62 Scaled Net Operating Assets is 0.62 as of Mar. 2026. GuruFocus rates MEX:MRVI with a GF Score™ of 62/100 and a GF Value™ of MXN52.80. The stock has 8 warning signs investors should review.

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Maravai LifeSciences Holdings's operating assets for the quarter that ended in Mar. 2026 was MXN9,869 Mil. Maravai LifeSciences Holdings's operating liabilities for the quarter that ended in Mar. 2026 was MXN1,321 Mil. Maravai LifeSciences Holdings's Total Assets for the quarter that ended in Dec. 2025 was MXN13,875 Mil. Therefore, Maravai LifeSciences Holdings's scaled net operating assets (SNOA) for the quarter that ended in Mar. 2026 was 0.62.


Maravai LifeSciences Holdings Scaled Net Operating Assets Historical Data

* Premium members only.

The historical data trend for Maravai LifeSciences Holdings's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Maravai LifeSciences Holdings Scaled Net Operating Assets Chart

Maravai LifeSciences Holdings Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Scaled Net Operating Assets
Get a 7-Day Free Trial 0.46 0.43 0.32 0.52 0.45

Maravai LifeSciences Holdings Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Scaled Net Operating Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.60 0.54 0.60 0.60 0.62

MEX:MRVI vs LBRX, SLDB, JANX: Scaled Net Operating Assets Comparison

For the Biotechnology subindustry, Maravai LifeSciences Holdings's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Maravai LifeSciences Holdings Scaled Net Operating Assets vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Maravai LifeSciences Holdings's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Maravai LifeSciences Holdings's Scaled Net Operating Assets falls into.


MEX:MRVI
62GF Score
Maravai LifeSciences Holdings Inc MEX:MRVI
Scaled Net Operating Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Maravai LifeSciences Holdings Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Maravai LifeSciences Holdings's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2025 is calculated as

Scaled Net Operating Assets (SNOA)(A: Dec. 2025 )
=(Operating Assets (A: Dec. 2025 )-Operating Liabilities (A: Dec. 2025 ))/Total Assets (A: Dec. 2024 )
=(9969.522-597.033)/21027.634
=0.45

where

Operating Assets(A: Dec. 2025 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=13874.778 - 3905.256
=9969.522

Operating Liabilities(A: Dec. 2025 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=7163.856 - 6311.124 - 255.699
=597.033

Maravai LifeSciences Holdings's Scaled Net Operating Assets (SNOA) for the quarter that ended in Mar. 2026 is calculated as

Scaled Net Operating Assets (SNOA)(Q: Mar. 2026 )
=(Operating Assets (Q: Mar. 2026 )-Operating Liabilities (Q: Mar. 2026 ))/Total Assets (Q: Dec. 2025 )
=(9869.206-1320.967)/13874.778
=0.62

where

Operating Assets(Q: Mar. 2026 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=12861.228 - 2992.022
=9869.206

Operating Liabilities(Q: Mar. 2026 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=6205.665 - 4786.6 - 98.098
=1320.967

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Scaled Net Operating Assets of 0.62 mean?
Maravai LifeSciences Holdings (MEX:MRVI) has a Scaled Net Operating Assets of 0.62 as of Mar. 2026. Scaled net operating assets equals current-period operating assets less operating liabilities less prior-period total assets. View historical data on Maravai LifeSciences Holdings and its competitors.
Is Maravai LifeSciences Holdings' Scaled Net Operating Assets too high?
Maravai LifeSciences Holdings' current Scaled Net Operating Assets is 0.62. Overall, Maravai LifeSciences Holdings has a GF Score™ of 62/100, reflecting its overall financial health beyond just this single metric.
How does Maravai LifeSciences Holdings' Scaled Net Operating Assets compare to LBRX and SLDB?
Maravai LifeSciences Holdings' Scaled Net Operating Assets of 0.62 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Scaled Net Operating Assets for a Biotechnology company?
A good Scaled Net Operating Assets depends on the Biotechnology industry context. However, Scaled Net Operating Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Scaled Net Operating Assets mean?
A high Scaled Net Operating Assets can signal that a stock is expensive relative to its fundamentals. Scaled net operating assets equals current-period operating assets less operating liabilities less prior-period total assets. View historical data on Maravai LifeSciences Holdings and its competitors. Maravai LifeSciences Holdings's current Scaled Net Operating Assets is 0.62. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Maravai LifeSciences Holdings stock overvalued right now?
Maravai LifeSciences Holdings (MEX:MRVI) has a current Scaled Net Operating Assets of 0.62. The stock's GF Value™ is MXN52.80, compared to a current price of MXN85.00 — trading 61% above its estimated fair value. The current Scaled Net Operating Assets is 0.62. Maravai LifeSciences Holdings' overall GF Score™ is 62/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Scaled Net Operating Assets calculated?
Scaled Net Operating Assets is calculated from a company's financial statements. For Maravai LifeSciences Holdings (MEX:MRVI), the current Scaled Net Operating Assets is 0.62 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Maravai LifeSciences Holdings (MEX:MRVI) Overvalued in 2026?

Based on GuruFocus' analysis, Maravai LifeSciences Holdings stock appears to be overvalued. The current stock price of MXN85.00 is trading 61% above its estimated GF Value™ of MXN52.80.

Key valuation signals for MEX:MRVI:

  • Scaled Net Operating Assets: 0.62
  • GF Value™: MXN52.80 vs. price of MXN85.00 (61% above fair value)
  • GF Score™: 62/100 with 8 warning signs

No single metric tells the full story. See the MEX:MRVI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Maravai LifeSciences Holdings Business Description

Other Exchanges MRVI:USAMAR:Germany
Address 10770 Wateridge Circle, Suite 200, San Diego, CA, USA, 92121
Maravai LifeSciences Holdings Inc is a life sciences company providing products and services to enable the development of drugs, therapeutics, vaccines and diagnostics, and to support research on human disease. Its product portfolio includes complex nucleic acids, custom enzymes and antibody-based solutions for therapeutic, vaccine, diagnostic and biopharmaceutical production applications. The Company operates through two segments: TriLink, which generates maximum revenue from North America and provides nucleic acid products and services including mRNA, oligonucleotides and related technologies; and Cygnus, which provides biologics safety testing products and services including host cell protein ELISA kits, impurity detection assays and related reagents and services.
62GF Score

Get the complete analysis for MEX:MRVI

Scaled Net Operating Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN85.00
Price
MXN52.80
GF Value